The Government Accountability Office (GAO) said in the March 24 report that the lack of finalized rules and the FDA not sharing how it determines financial conflicts of interest for members of its advisory committees is harming transparency. The FDA’s website had information on

The Government Accountability Office (GAO) said in the March 24 report that the lack of finalized rules and the FDA not sharing how it determines financial conflicts of interest for members of its advisory committees is harming transparency. The FDA’s website had information on

Go to News Site